(6-246) Evaluating weight loss among patients with type 2 diabetes mellitus (T2DM) newly treated with tirzepatide or switched from other glucagon-like 1 peptide receptor agonist (GLP1-RA).
Tuesday, December 10, 2024
10:45 AM – 11:45 AM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Ambulatory Care
Co-Author(s): Michael S. Kelly, Emily M. Scopelliti
